Skip to content

Screener

Eligibility screening

CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemoref…

Sponsored by Northwestern UniversityStudy detailsClinicalTrials.gov

1 US site in IL

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.